Hirokazu Endo

Comptroller/Controller/Auditor bei ZERIA PHARMACEUTICAL CO., LTD.

Vermögen: 1 Mio $ am 30.04.2024

71 Jahre

Health Technology

Profil

Hirokazu Endo currently works at Tillotts Pharma AG, as Non-Executive Director and Zeria Pharmaceutical Co., Ltd., as Auditor.

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
ZERIA PHARMACEUTICAL CO., LTD. 0,14%	31.03.2023	77 000 ( 0,14% )	1 Mio $	30.04.2024

Unternehmen	Position	Beginn
ZERIA PHARMACEUTICAL CO., LTD.	Comptroller/Controller/Auditor	-
Tillotts Pharma AG Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland.	Director/Board Member	05.07.2011

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Private Unternehmen	2
Tillotts Pharma AG Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland.	Health Technology
Zeria Pharmaceutical Co., Ltd.